X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1664) 1664
Publication (305) 305
Book Chapter (39) 39
Book Review (22) 22
Conference Proceeding (10) 10
Dissertation (3) 3
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
neurosciences (1197) 1197
animals (1138) 1138
index medicus (791) 791
male (563) 563
rats (523) 523
humans (502) 502
striatal neurons (402) 402
dopamine (400) 400
basal ganglia (359) 359
mice (323) 323
neurons (268) 268
brain (237) 237
female (236) 236
pharmacology & pharmacy (235) 235
rats, sprague-dawley (233) 233
parkinsons-disease (226) 226
parkinson's disease (225) 225
long-term potentiation (222) 222
synaptic plasticity (222) 222
neurology (210) 210
dopamine - metabolism (209) 209
article (205) 205
striatum (200) 200
glutamate (196) 196
disease models, animal (183) 183
striatal dopamine (169) 169
psychiatry (168) 168
analysis (163) 163
nervous system (160) 160
neurons - metabolism (155) 155
biochemistry & molecular biology (154) 154
clinical neurology (151) 151
neostriatum (139) 139
neurons - physiology (137) 137
rats, wistar (136) 136
nucleus-accumbens (135) 135
neurons - drug effects (132) 132
rodents (127) 127
corpus striatum - metabolism (126) 126
reward (121) 121
neuronal plasticity - physiology (120) 120
physiological aspects (119) 119
prefrontal cortex (119) 119
mice, inbred c57bl (117) 117
neuroscience (117) 117
striatal dopamine release (116) 116
cells, cultured (109) 109
immunohistochemistry (109) 109
medium spiny neurons (109) 109
plasticity (109) 109
substantia-nigra (108) 108
in-vivo (104) 104
research (103) 103
ventral tegmental area (100) 100
gene-expression (99) 99
huntington's disease (99) 99
time factors (99) 99
corpus striatum - drug effects (97) 97
cortex (97) 97
brain - metabolism (94) 94
dose-response relationship, drug (92) 92
phenols (92) 92
rat (91) 91
central-nervous-system (89) 89
synaptic transmission - physiology (89) 89
nucleus accumbens (88) 88
striatal synaptic plasticity (87) 87
behavioral sciences (85) 85
gaba (84) 84
phosphorylation (84) 84
schizophrenia (84) 84
mice, transgenic (83) 83
corpus striatum - physiology (82) 82
dopamine receptors (79) 79
in vitro techniques (79) 79
cocaine (78) 78
electrophysiology (76) 76
expression (76) 76
gene expression (76) 76
motor activity - drug effects (76) 76
cell biology (75) 75
messenger-rna (74) 74
movement disorders (74) 74
multidisciplinary sciences (74) 74
striatal projection neurons (74) 74
nervous system diseases (73) 73
reinforcement (73) 73
biomedicine (72) 72
neural pathways - physiology (72) 72
hippocampus (70) 70
dopamine - physiology (69) 69
excitatory amino acid antagonists - pharmacology (69) 69
long-term depression (69) 69
rat-brain (69) 69
proteins (68) 68
receptors, n-methyl-d-aspartate - metabolism (67) 67
striatal cholinergic interneurons (66) 66
brain - drug effects (65) 65
huntingtons-disease (65) 65
adult (64) 64
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1667) 1667
French (2) 2
Japanese (2) 2
Chinese (1) 1
German (1) 1
Italian (1) 1
Portuguese (1) 1
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Neurology, ISSN 0364-5134, 11/2010, Volume 68, Issue 5, pp. 619 - 628
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 10/2006, Volume 99, Issue 2, pp. 381 - 392
L‐3,4‐dihydroxyphenylalanine (L‐DOPA) remains the most efficacious drug for the treatment of Parkinson's disease (PD), but causes adverse effects that limit... 
intracellular signaling | blood‐brain barrier | dopamine transporters | basal ganglia | functional imaging | opioid | Opioid | Basal ganglia | Blood-brain barrier | Intracellular signaling | Dopamine transporters | Functional imaging | blood-brain barrier | AMINO-ACID DECARBOXYLASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | PRODYNORPHIN MESSENGER-RNA | ELEMENT-BINDING PROTEIN | ABNORMAL INVOLUNTARY MOVEMENTS | BLOOD-BRAIN-BARRIER | NEUROSCIENCES | STRIATAL SYNAPTIC PLASTICITY | LEVODOPA-INDUCED DYSKINESIA | VESICULAR MONOAMINE TRANSPORTER-2 | LONG-TERM DEPRESSION | NMDA RECEPTOR SUBUNITS | Dopamine Plasma Membrane Transport Proteins - metabolism | Synapses - drug effects | Synaptic Transmission - physiology | Dyskinesia, Drug-Induced - physiopathology | Basal Ganglia - physiopathology | Dopamine Plasma Membrane Transport Proteins - drug effects | Humans | Basal Ganglia - metabolism | Neuronal Plasticity - drug effects | Blood-Brain Barrier - drug effects | Blood-Brain Barrier - metabolism | Dopamine Agents - adverse effects | Animals | Neuronal Plasticity - physiology | Synapses - metabolism | Levodopa - adverse effects | Dyskinesia, Drug-Induced - metabolism | Dopamine - metabolism | Basal Ganglia - drug effects | Basic Medicine | Neurosciences | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Neurovetenskaper
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 05/2013, Volume 33, Issue 22, pp. 9353 - 9363
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 10/2019, Volume 50, Issue 7, pp. 3191 - 3204
Journal Article
Movement Disorders, ISSN 0885-3185, 11/2014, Volume 29, Issue 13, pp. 1655 - 1665
Broad-spectrum muscarinic receptor antagonists have represented the first available treatment for different movement disorders such as dystonia. However, the... 
Striatum | Muscarinic receptor antagonists | Dystonia | Synaptic plasticity | SUBTYPE | IMMUNOCYTOCHEMISTRY | muscarinic receptor antagonists | BASAL GANGLIA | AUTORECEPTOR FUNCTION | CLINICAL NEUROLOGY | TRANSMISSION | striatum | dystonia | MOUSE MODEL | NEURONS | STRIATAL CHOLINERGIC INTERNEURONS | synaptic plasticity | LONG-TERM POTENTIATION | MODULATION
Journal Article
Movement Disorders, ISSN 0885-3185, 07/2017, Volume 32, Issue 7, pp. 1035 - 1046
ABSTRACT Background: Recent studies support the therapeutic utility of repetitive transcranial magnetic stimulation in Parkinson's disease (PD), whose... 
corticostriatal synaptic plasticity | Parkinson's disease | transcranial magnetic stimulation | long‐term potentiation | glia | long-term potentiation | DEPRESSION | RAT | INCREASES | RELEASE | PREFRONTAL CORTEX | CLINICAL NEUROLOGY | NEUROINFLAMMATION | DISEASE | NEURONS | STRIATAL PLASTICITY | Motor Activity - physiology | Corpus Striatum - physiopathology | Rats, Wistar | Genes, Immediate-Early - physiology | Rats | Behavior, Animal - physiology | Male | Parkinsonian Disorders - chemically induced | Transcranial Magnetic Stimulation - methods | Adrenergic Agents - pharmacology | Corpus Striatum - metabolism | Cerebral Cortex - metabolism | Cerebral Cortex - physiopathology | Astrocytes - physiology | Patch-Clamp Techniques | Animals | Microdialysis | Microglia - physiology | Neuronal Plasticity - physiology | Oxidopamine - pharmacology | Parkinsonian Disorders - therapy | Dopamine - metabolism | Theta Rhythm - physiology | Physiological aspects | Phenols | Development and progression | Analysis | Adaptations | Potentiation | Basal ganglia | Plasticity (glial) | Glial cells | Motor task performance | Neuromodulation | Neuronal-glial interactions | Cell activation | Rodents | Neostriatum | Long-term depression | Movement disorders | Dopamine | Neurodegenerative diseases | Astrocytes | Long-term potentiation | Cortex | Attention | 6-Hydroxydopamine | Central nervous system diseases | Inflammation | Spiny neurons | Plasticity (synaptic) | Magnetic fields
Journal Article
Current Opinion in Neurobiology, ISSN 0959-4388, 02/2018, Volume 48, pp. 71 - 78
-DOPA provides highly effective treatment for Parkinson's disease, but -DOPA induced dyskinesia (LID) is a very debilitating response that eventually is... 
NIGRA PARS-RETICULATA | LEVODOPA-INDUCED DYSKINESIAS | STRIATAL PROJECTION NEURONS | GABA RELEASE | MOTOR | MICE | SUBSTANTIA-NIGRA | UP-REGULATION | NEUROSCIENCES | OSCILLATORY ACTIVITY | PARKINSONS-DISEASE
Journal Article